82_FR_17496 82 FR 17428 - Supplemental Evidence and Data Request on Systematic Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries

82 FR 17428 - Supplemental Evidence and Data Request on Systematic Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality

Federal Register Volume 82, Issue 68 (April 11, 2017)

Page Range17428-17430
FR Document2017-07157

The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review of Systematic Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries, which is currently being conducted by the AHRQ's Evidence-based Practice CentersProgram. Access to published and unpublished pertinent scientific information will improve the quality of this review.

Federal Register, Volume 82 Issue 68 (Tuesday, April 11, 2017) 
[Federal Register Volume 82, Number 68 (Tuesday, April 11, 2017)]
[Notices]
[Pages 17428-17430]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-07157]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Supplemental Evidence and Data Request on Systematic Review of 
Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal 
Health Outcomes in Developed Countries

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Request for supplemental evidence and data submissions.

-----------------------------------------------------------------------

SUMMARY: The Agency for Healthcare Research and Quality (AHRQ) is 
seeking scientific information submissions from the public. Scientific 
information is being solicited to inform our review of Systematic 
Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, 
and Maternal Health Outcomes in Developed Countries, which is currently 
being conducted by the AHRQ's Evidence-based Practice CentersProgram. 
Access to published and unpublished pertinent scientific information 
will improve the quality of this review.

DATES: Submission Deadline on or before May 11, 2017.

ADDRESSES: 
    Email submissions: src.org">SEADS@epc-src.org.
    Print submissions: Mailing Address: Portland VA Research 
Foundation, Scientific Resource Center, ATTN: Scientific Information 
Packet Coordinator, P.O. Box 69539, Portland, OR 97239.
    Shipping Address (FedEx, UPS, etc.): Portland VA Research 
Foundation, Scientific Resource Center, ATTN: Scientific Information 
Packet

[[Page 17429]]

Coordinator, 3710 SW U.S. Veterans Hospital Road, Mail Code: R&D 71, 
Portland, OR 97239.

FOR FURTHER INFORMATION CONTACT: Ryan McKenna, Telephone: 503-220-8262 
ext. 51723 or Email: src.org">SEADS@epc-src.org.

SUPPLEMENTARY INFORMATION: The Agency for Healthcare Research and 
Quality has commissioned the Evidence-based Practice Centers (EPC) 
Program to complete a review of the evidence for Systematic Review of 
Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal 
Health Outcomes in Developed Countries. AHRQ is conducting this 
systematic review pursuant to Section 902(a) of the Public Health 
Service Act, 42 U.S.C. 299a(a).
    The EPC Program is dedicated to identifying as many studies as 
possible that are relevant to the questions for each of its reviews. In 
order to do so, we are supplementing the usual manual and electronic 
database searches of the literature by requesting information from the 
public (e.g., details of studies conducted). We are looking for studies 
that report on Systematic Review of Breastfeeding Programs and 
Policies, Breastfeeding Uptake, and Maternal Health Outcomes in 
Developed Countries, including those that describe adverse events. The 
entire research protocol, including the key questions, is also 
available online at: https://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productID=2455
    This is to notify the public that the EPC Program would find the 
following information on Systematic Review of Breastfeeding Programs 
and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in 
Developed Countries helpful:
    [ssquf] A list of completed studies that your organization has 
sponsored for this indication. In the list, please indicate whether 
results are available on ClinicalTrials.gov along with the 
ClinicalTrials.gov trial number.
    [ssquf] For completed studies that do not have results on 
ClinicalTrials.gov, please provide a summary, including the following 
elements: Study number, study period, design, methodology, indication 
and diagnosis, proper use instructions, inclusion and exclusion 
criteria, primary and secondary outcomes, baseline characteristics, 
number of patients screened/eligible/enrolled/lost to follow-up/
withdrawn/analyzed, effectiveness/efficacy, and safety results.
    [ssquf] A list of ongoing studies that your organization has 
sponsored for this indication. In the list, please provide the 
ClinicalTrials.gov trial number or, if the trial is not registered, the 
protocol for the study including a study number, the study period, 
design, methodology, indication and diagnosis, proper use instructions, 
inclusion and exclusion criteria, and primary and secondary outcomes.
    [ssquf] Description of whether the above studies constitute ALL 
Phase II and above clinical trials sponsored by your organization for 
this indication and an index outlining the relevant information in each 
submitted file.
    Your contribution will be very beneficial to the EPC Program. The 
contents of all submissions will be made available to the public upon 
request. Materials submitted must be publicly available or able to be 
made public. Materials that are considered confidential; marketing 
materials; study types not included in the review; or information on 
indications not included in the review cannot be used by the EPC 
Program. This is a voluntary request for information, and all costs for 
complying with this request must be borne by the submitter.
    The draft of this review will be posted on AHRQ's EPC Program Web 
site and available for public comment for a period of 4 weeks. If you 
would like to be notified when the draft is posted, please sign up for 
the email list at: https://www.effectivehealthcare.ahrq.gov/index.cfm/join-the-email-list1/.
    The systematic review will answer the following questions. This 
information is provided as background. AHRQ is not requesting that the 
public provide answers to these questions.

The Key Questions

    KQ 1a. What is the effectiveness and harms of programs and policies 
on initiation, duration, and exclusivity of breastfeeding?
    KQ 1b. To what extent do the effectiveness and harms of programs 
and policies on initiation, duration, and exclusivity of breastfeeding 
differ for subpopulations of women defined by sociodemographic factors 
(e.g., age, race, ethnicity, socioeconomic status)?
    KQ 1c. To what extent do intervention-related characteristics 
(e.g., type of breast pump provided--manual or electric; delivery 
personnel) influence the initiation, duration, and exclusivity of 
breast feeding?
    KQ 2a. What are the comparative benefits and harms for maternal 
health outcomes among women who breastfeed for different intensities 
and durations?
    KQ 2b. To what extent do benefits and harms for maternal health 
outcomes differ for subpopulations of women defined by age, race, 
ethnicity, and comorbidity?

Population(s)

    KQs 1, 2: Childbearing women and adolescents; we will also search 
for evidence on subgroups of women defined by age, race, ethnicity, 
comorbidity, and socioeconomic status (including insurance status and 
payer type).

Interventions/Exposure

    KQ 1: Community, workplace, and health care system-based 
interventions aimed at promoting and supporting breastfeeding, 
including the following: Health plan benefits, state and federal 
policies or programs (e.g., WIC programs), hospital implementation of 
the BFHI, workplace or school-based programs, and others. For studies 
assessing the effectiveness of BFHI, we will include studies evaluating 
full and partial implementation (at least 3 steps) of the 10 steps.
    KQ 2: Exposure to breastfeeding.

Comparators

    KQ 1: No intervention (or usual practice); comparisons of two 
interventions that differ in content or intensity.
    KQ 2: No breastfeeding; shorter duration of breastfeeding (e.g., 
breastfeeding for 1 month vs. 12 months) and/or less intensive 
breastfeeding (e.g., exclusive breastfeeding vs. mixed feeding or 
formula feeding).

Outcomes

    KQ 1: Rates of breastfeeding initiation; duration and exclusivity 
of breastfeeding, adverse effects of interventions (e.g., guilt about 
not breastfeeding, workplace discrimination, and other reported harms).
    KQ 2: Postpartum depression, breast cancer, ovarian cancer, 
osteoporosis, cardiovascular outcomes (e.g., stroke, myocardial 
infarction), postpartum weight change, type 2 diabetes, hypertension.

Timing

    KQs 1, 2: We will have no minimum study duration or length of 
follow up.

Settings

    KQs 1, 2: Studies conducted in a developed country [``very high'' 
(KQs 1, 2) and ``high'' (KQ 1) human development index per the United 
Nations Development Programme 40.

[[Page 17430]]

Study Design

    KQ 1: Randomized and non-randomized controlled clinical trials; 
prospective cohort studies with concurrent control groups; systematic 
reviews; for studies assessing policy or system-level interventions, we 
will also include pre-post studies with repeated outcome measures 
before and after the intervention.
    KQ 2: Randomized and non-randomized controlled clinical trials; 
cohort studies; case-control studies; systematic reviews.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-07157 Filed 4-10-17; 8:45 am]
 BILLING CODE 4160-90-P

17428 Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices Method of Collection due AHRQ notifies principal federally mandated programs and To achieve the goals of this project, investigators and vendors via email. regulations. the following data collections will be The ARRS is an automated, user- Estimated Annual Respondent Burden implemented: friendly resource that is utilized by AHRQ Research Reporting System AHRQ staff for preparing, distributing, Exhibit 1 shows the estimated (ARRS)—Grantees and vendors use the and reviewing reporting requests to annualized burden hours for the ARRS system to report project progress grantees and vendors for the purpose of respondents. It will take grantees and and important preliminary findings for information sharing. AHRQ personnel vendors an estimated 10 minutes to grants and contracts funded by the are able to systematically search the enter the necessary data into the ARRS Agency. Grantees and vendors submit information collected and stored in the System and reporting will occur four progress reports on a monthly or ARRS database. Personnel will also use times annually. The total annualized quarterly basis which are reviewed by the information to address internal and/ burden hours are estimated to be 333 AHRQ personnel. All users access the or external requests for information hours. ARRS system through a secure online regarding grant progress, preliminary Exhibit 2 shows the estimated interface which requires a user I.D. and findings, and other requests, such as annualized cost burden for the password entered through the ARRS Freedom of Information Act requests respondents. The total estimated cost login screen. When status reports are and producing responses related to burden for respondents is $12,454. EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS Number of Number of Hours per Total Form name responses per respondents response burden hours respondent Data entry into ARRS ...................................................................................... 500 4 10/60 333 Total .......................................................................................................... 500 N/A N/A 333 EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN Average Number of Total burden Total cost Form name hourly wage respondents hours burden rate * Data entry into ARRS ...................................................................................... 500 333 $37.40 $12,454 Total .......................................................................................................... 500 333 N/A 12,454 * Based upon the average wages for Healthcare Practitioner and Technical Occupations (29–0000), ‘‘National Compensation Survey: Occupa- tional Wages in the United States, May 2015,’’ U.S. Department of Labor, Bureau of Labor Statistics, http://www.bls.gov/oes/current/oes_ nat.htm#29-0000. Request for Comments comments will become a matter of scientific information submissions from public record. the public. Scientific information is In accordance with the Paperwork being solicited to inform our review of Reduction Act, comments on AHRQ’s Sharon B. Arnold, Systematic Review of Breastfeeding information collection are requested Acting Director. Programs and Policies, Breastfeeding with regard to any of the following: (a) [FR Doc. 2017–07156 Filed 4–10–17; 8:45 am] Uptake, and Maternal Health Outcomes Whether the proposed collection of BILLING CODE 4160–90–P in Developed Countries, which is information is necessary for the proper currently being conducted by the performance of AHRQ health care AHRQ’s Evidence-based Practice research and health care information DEPARTMENT OF HEALTH AND CentersProgram. Access to published dissemination functions, including HUMAN SERVICES and unpublished pertinent scientific whether the information will have information will improve the quality of practical utility; (b) the accuracy of Agency for Healthcare Research and this review. AHRQ’s estimate of burden (including Quality DATES: Submission Deadline on or hours and costs) of the proposed before May 11, 2017. collection(s) of information; (c) ways to Supplemental Evidence and Data Request on Systematic Review of ADDRESSES: enhance the quality, utility and clarity Email submissions: SEADS@epc- of the information to be collected; and Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal src.org. (d) ways to minimize the burden of the Print submissions: Mailing Address: collection of information upon the Health Outcomes in Developed Countries Portland VA Research Foundation, respondents, including the use of Scientific Resource Center, ATTN: srobinson on DSK5SPTVN1PROD with NOTICES automated collection techniques or AGENCY: Agency for Healthcare Research Scientific Information Packet other forms of information technology. and Quality (AHRQ), HHS. Coordinator, P.O. Box 69539, Portland, Comments submitted in response to ACTION: Request for supplemental OR 97239. this notice will be summarized and evidence and data submissions. Shipping Address (FedEx, UPS, etc.): included in the Agency’s subsequent Portland VA Research Foundation, request for OMB approval of the SUMMARY: The Agency for Healthcare Scientific Resource Center, ATTN: proposed information collection. All Research and Quality (AHRQ) is seeking Scientific Information Packet VerDate Sep<11>2014 20:18 Apr 10, 2017 Jkt 241001 PO 00000 Frm 00022 Fmt 4703 Sfmt 4703 E:\FR\FM\11APN1.SGM 11APN1

Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices 17429 Coordinator, 3710 SW U.S. Veterans D A list of ongoing studies that your KQ 2b. To what extent do benefits Hospital Road, Mail Code: R&D 71, organization has sponsored for this and harms for maternal health outcomes Portland, OR 97239. indication. In the list, please provide the differ for subpopulations of women FOR FURTHER INFORMATION CONTACT: ClinicalTrials.gov trial number or, if the defined by age, race, ethnicity, and Ryan McKenna, Telephone: 503–220– trial is not registered, the protocol for comorbidity? 8262 ext. 51723 or Email: SEADS@epc- the study including a study number, the Population(s) src.org. study period, design, methodology, indication and diagnosis, proper use KQs 1, 2: Childbearing women and SUPPLEMENTARY INFORMATION: The instructions, inclusion and exclusion adolescents; we will also search for Agency for Healthcare Research and criteria, and primary and secondary evidence on subgroups of women Quality has commissioned the outcomes. defined by age, race, ethnicity, Evidence-based Practice Centers (EPC) D Description of whether the above comorbidity, and socioeconomic status Program to complete a review of the studies constitute ALL Phase II and (including insurance status and payer evidence for Systematic Review of above clinical trials sponsored by your type). Breastfeeding Programs and Policies, organization for this indication and an Breastfeeding Uptake, and Maternal Interventions/Exposure index outlining the relevant information Health Outcomes in Developed in each submitted file. KQ 1: Community, workplace, and Countries. AHRQ is conducting this Your contribution will be very health care system-based interventions systematic review pursuant to Section beneficial to the EPC Program. The aimed at promoting and supporting 902(a) of the Public Health Service Act, contents of all submissions will be made breastfeeding, including the following: 42 U.S.C. 299a(a). available to the public upon request. Health plan benefits, state and federal The EPC Program is dedicated to Materials submitted must be publicly policies or programs (e.g., WIC identifying as many studies as possible available or able to be made public. programs), hospital implementation of that are relevant to the questions for Materials that are considered the BFHI, workplace or school-based each of its reviews. In order to do so, we confidential; marketing materials; study programs, and others. For studies are supplementing the usual manual types not included in the review; or assessing the effectiveness of BFHI, we and electronic database searches of the information on indications not included will include studies evaluating full and literature by requesting information in the review cannot be used by the EPC partial implementation (at least 3 steps) from the public (e.g., details of studies Program. This is a voluntary request for of the 10 steps. conducted). We are looking for studies information, and all costs for complying KQ 2: Exposure to breastfeeding. that report on Systematic Review of with this request must be borne by the Comparators Breastfeeding Programs and Policies, submitter. Breastfeeding Uptake, and Maternal The draft of this review will be posted KQ 1: No intervention (or usual Health Outcomes in Developed on AHRQ’s EPC Program Web site and practice); comparisons of two Countries, including those that describe available for public comment for a interventions that differ in content or adverse events. The entire research period of 4 weeks. If you would like to intensity. protocol, including the key questions, is be notified when the draft is posted, KQ 2: No breastfeeding; shorter also available online at: https:// please sign up for the email list at: duration of breastfeeding (e.g., effectivehealthcare.ahrq.gov/search-for- https:// breastfeeding for 1 month vs. 12 guides-reviews-and-reports/ www.effectivehealthcare.ahrq.gov/ months) and/or less intensive ?pageaction=displayproduct index.cfm/join-the-email-list1/. breastfeeding (e.g., exclusive &productID=2455 The systematic review will answer the breastfeeding vs. mixed feeding or This is to notify the public that the following questions. This information is formula feeding). EPC Program would find the following provided as background. AHRQ is not Outcomes information on Systematic Review of requesting that the public provide answers to these questions. KQ 1: Rates of breastfeeding initiation; Breastfeeding Programs and Policies, duration and exclusivity of Breastfeeding Uptake, and Maternal The Key Questions breastfeeding, adverse effects of Health Outcomes in Developed KQ 1a. What is the effectiveness and interventions (e.g., guilt about not Countries helpful: harms of programs and policies on breastfeeding, workplace D A list of completed studies that initiation, duration, and exclusivity of discrimination, and other reported your organization has sponsored for this breastfeeding? harms). indication. In the list, please indicate KQ 1b. To what extent do the KQ 2: Postpartum depression, breast whether results are available on effectiveness and harms of programs cancer, ovarian cancer, osteoporosis, ClinicalTrials.gov along with the and policies on initiation, duration, and cardiovascular outcomes (e.g., stroke, ClinicalTrials.gov trial number. exclusivity of breastfeeding differ for myocardial infarction), postpartum D For completed studies that do not subpopulations of women defined by weight change, type 2 diabetes, have results on ClinicalTrials.gov, sociodemographic factors (e.g., age, race, hypertension. please provide a summary, including ethnicity, socioeconomic status)? the following elements: Study number, KQ 1c. To what extent do Timing study period, design, methodology, intervention-related characteristics (e.g., KQs 1, 2: We will have no minimum indication and diagnosis, proper use type of breast pump provided—manual srobinson on DSK5SPTVN1PROD with NOTICES study duration or length of follow up. instructions, inclusion and exclusion or electric; delivery personnel) criteria, primary and secondary Settings influence the initiation, duration, and outcomes, baseline characteristics, exclusivity of breast feeding? KQs 1, 2: Studies conducted in a number of patients screened/eligible/ KQ 2a. What are the comparative developed country [‘‘very high’’ (KQs 1, enrolled/lost to follow-up/withdrawn/ benefits and harms for maternal health 2) and ‘‘high’’ (KQ 1) human analyzed, effectiveness/efficacy, and outcomes among women who breastfeed development index per the United safety results. for different intensities and durations? Nations Development Programme 40. VerDate Sep<11>2014 20:18 Apr 10, 2017 Jkt 241001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\11APN1.SGM 11APN1

17430 Federal Register / Vol. 82, No. 68 / Tuesday, April 11, 2017 / Notices Study Design SUPPLEMENTARY INFORMATION: The Your contribution will be very KQ 1: Randomized and non- Agency for Healthcare Research and beneficial to the EPC Program. The randomized controlled clinical trials; Quality has commissioned the contents of all submissions will be made prospective cohort studies with Evidence-based Practice Centers (EPC) available to the public upon request. concurrent control groups; systematic Program to complete a review of the Materials submitted must be publicly reviews; for studies assessing policy or evidence for Lower Limb Prosthesis available or able to be made public. system-level interventions, we will also (LLP). AHRQ is conducting this Materials that are considered include pre-post studies with repeated systematic review pursuant to Section confidential; marketing materials; study outcome measures before and after the 902(a) of the Public Health Service Act, types not included in the review; or intervention. 42 U.S.C. 299a(a). information on indications not included KQ 2: Randomized and non- The EPC Program is dedicated to in the review cannot be used by the EPC randomized controlled clinical trials; identifying as many studies as possible Program. This is a voluntary request for cohort studies; case-control studies; that are relevant to the questions for information, and all costs for complying systematic reviews. each of its reviews. In order to do so, we with this request must be borne by the are supplementing the usual manual submitter. Sharon B. Arnold, and electronic database searches of the The draft of this review will be posted Acting Director. literature by requesting information on AHRQ’s EPC Program Web site and [FR Doc. 2017–07157 Filed 4–10–17; 8:45 am] from the public (e.g., details of studies available for public comment for a BILLING CODE 4160–90–P conducted). We are looking for studies period of 4 weeks. If you would like to that report on Lower Limb Prosthesis, be notified when the draft is posted, including those that describe adverse please sign up for the email list at: DEPARTMENT OF HEALTH AND events. The entire research protocol, https://www.effectivehealthcare. HUMAN SERVICES including the key questions, is also ahrq.gov/index.cfm/join-the-email-list1/ available online at: https:// . Agency for Healthcare Research and effectivehealthcare.ahrq.gov/search-for- The systematic review will answer the Quality guides-reviews-and-reports/ following questions. This information is ?pageaction=displayproduct&product provided as background. AHRQ is not Supplemental Evidence and Data requesting that the public provide ID=2451 Request on Lower Limb Prosthesis answers to these questions. This is to notify the public that the AGENCY: Agency for Healthcare Research EPC Program would find the following The Key Questions and Quality (AHRQ), HHS. information on Lower Limb Prosthesis helpful: Key Question 1 ACTION: Request for supplemental evidence and data submissions. D A list of completed studies that What assessment techniques used to your organization has sponsored for this measure functional ability of adults SUMMARY: The Agency for Healthcare indication. In the list, please indicate with major lower limb amputation have Research and Quality (AHRQ) is seeking whether results are available on been evaluated in the published scientific information submissions from ClinicalTrials.gov along with the literature? the public. Scientific information is ClinicalTrials.gov trial number. I. What are the measurement being solicited to inform our review of D For completed studies that do not properties of these techniques, Lower Limb Prosthesis, which is have results on ClinicalTrials.gov, including: Reliability, validity, currently being conducted by the please provide a summary, including responsiveness, minimal detectable AHRQ’s Evidence-based Practice the following elements: study number, change, and minimal important Centers Program. Access to published study period, design, methodology, difference? and unpublished pertinent scientific indication and diagnosis, proper use II. What are the characteristics of the information will improve the quality of instructions, inclusion and exclusion participants in studies evaluating this review. criteria, primary and secondary measurement properties of assessment DATES: Submission Deadline on or outcomes, baseline characteristics, techniques? before May 11, 2017. number of patients screened/eligible/ Key Question 2 ADDRESSES: enrolled/lost to follow-up/withdrawn/ What prediction tools used to predict Email submissions: SEADS@epc- analyzed, effectiveness/efficacy, and functional outcomes in adults with src.org. safety results. major lower limb amputation have been Print submissions: D A list of ongoing studies that your evaluated in the published literature? Mailing Address: Portland VA organization has sponsored for this I. What are their characteristics, Research Foundation, Scientific indication. In the list, please provide the including technical quality (reliability, Resource Center, ATTN: Scientific ClinicalTrials.gov trial number or, if the validity, responsiveness), minimal Information Packet Coordinator, P.O. trial is not registered, the protocol for detectable change, and minimal Box 69539, Portland, OR 97239. the study including a study number, the important difference? Shipping Address (FedEx, UPS, etc.): study period, design, methodology, II. What are the characteristics of the Portland VA Research Foundation, indication and diagnosis, proper use participants in these studies? Scientific Resource Center, ATTN: instructions, inclusion and exclusion Scientific Information Packet criteria, and primary and secondary Key Question 3 srobinson on DSK5SPTVN1PROD with NOTICES Coordinator, 3710 SW U.S. Veterans outcomes. What functional outcome Hospital Road, Mail Code: R&D 71, D Description of whether the above measurement tools used to assess adults Portland, OR 97239. studies constitute ALL Phase II and who use a lower limb prosthesis (LLP) FOR FURTHER INFORMATION CONTACT: above clinical trials sponsored by your have been evaluated in the published Ryan McKenna, Telephone: 503–220– organization for this indication and an literature? 8262 ext. 51723 or Email: SEADS@epc- index outlining the relevant information I. What are their characteristics, src.org. in each submitted file. including technical quality (reliability, VerDate Sep<11>2014 20:18 Apr 10, 2017 Jkt 241001 PO 00000 Frm 00024 Fmt 4703 Sfmt 4703 E:\FR\FM\11APN1.SGM 11APN1


Document Created: 2017-04-11 00:48:38
Document Modified: 2017-04-11 00:48:38
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionRequest for supplemental evidence and data submissions.
DatesSubmission Deadline on or before May 11, 2017.
ContactRyan McKenna, Telephone: 503-220-8262 ext. 51723 or Email: [email protected]
FR Citation82 FR 17428 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR